Stock Track | Moderna Soars 5.03% Intraday on Multiple Analyst Price Target Hikes

Stock Track

Yesterday

Moderna, Inc. (MRNA) experienced a significant surge of 5.03% during intraday trading on Monday, as the stock price climbed sharply following a series of positive analyst actions.

The rally was fueled by multiple investment firms raising their price targets for the biotech company. UBS increased its target to $45 from $36 while maintaining a Neutral rating, RBC Capital raised its target to $38 from $35 with a Sector Perform rating, and Evercore ISI significantly boosted its target to $50 from $35 while keeping an In Line rating on the shares.

Additional analyst activity included Piper Sandler reiterating a Buy rating with a $69 price target and Barclays maintaining a Hold rating with a $48 target. These coordinated analyst actions suggesting improved valuation expectations contributed to heightened investor optimism and buying activity in Moderna shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1170205684"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1170205684\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1170205684?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 22:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170205684","market":"sg","top_or_hot":-1,"title":"Stock Track | Moderna Soars 5.03% Intraday on Multiple Analyst Price Target Hikes","media":"Stock Track","content":"<p>Moderna, Inc. (MRNA) experienced a significant surge of 5.03% during intraday trading on Monday, as the stock price climbed sharply following a series of positive analyst actions.</p><p>The rally was fueled by multiple investment firms raising their price targets for the biotech company. UBS increased its target to $45 from $36 while maintaining a Neutral rating, RBC Capital raised its target to $38 from $35 with a Sector Perform rating, and Evercore ISI significantly boosted its target to $50 from $35 while keeping an In Line rating on the shares.</p><p>Additional analyst activity included Piper Sandler reiterating a Buy rating with a $69 price target and Barclays maintaining a Hold rating with a $48 target. These coordinated analyst actions suggesting improved valuation expectations contributed to heightened investor optimism and buying activity in Moderna shares.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Soars 5.03% Intraday on Multiple Analyst Price Target Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Soars 5.03% Intraday on Multiple Analyst Price Target Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-04 22:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc. (MRNA) experienced a significant surge of 5.03% during intraday trading on Monday, as the stock price climbed sharply following a series of positive analyst actions.</p><p>The rally was fueled by multiple investment firms raising their price targets for the biotech company. UBS increased its target to $45 from $36 while maintaining a Neutral rating, RBC Capital raised its target to $38 from $35 with a Sector Perform rating, and Evercore ISI significantly boosted its target to $50 from $35 while keeping an In Line rating on the shares.</p><p>Additional analyst activity included Piper Sandler reiterating a Buy rating with a $69 price target and Barclays maintaining a Hold rating with a $48 target. These coordinated analyst actions suggesting improved valuation expectations contributed to heightened investor optimism and buying activity in Moderna shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1170205684","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170205684","pubTimestamp":1777904084,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc. (MRNA) experienced a significant surge of 5.03% during intraday trading on Monday, as the stock price climbed sharply following a series of positive analyst actions.The rally was fueled...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"个股追踪|多位分析师上调目标价Moderna盘中大涨5.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (MRNA) experienced a significant surge of 5.03% during intraday trading on Monday, as the stock price climbed sharply following a series of positive analyst actions.The rally was fueled by multiple investment firms raising their price targets for the biotech company. UBS increased its target to $45 from $36 while maintaining a Neutral rating, RBC Capital raised its target to $38 from $35 with a Sector Perform rating, and Evercore ISI significantly boosted its target to $50 from $35 while keeping an In Line rating on the shares.Additional analyst activity included Piper Sandler reiterating a Buy rating with a $69 price target and Barclays maintaining a Hold rating with a $48 target. These coordinated analyst actions suggesting improved valuation expectations contributed to heightened investor optimism and buying activity in Moderna shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}